Residual disease after mastectomy

Affiliations

¹ Manchester University NHS Foundation Trust, Wythenshawe, Manchester M23 9LT, UK. Electronic address: bundredn@manchester.ac.uk.
² Nuffield Department of Population Health, University of Oxford, Oxford, UK.
³ Leeds Teaching Hospital NHS Trust, Leeds, UK.
⁴ University Hospital Southampton, Southampton, UK.

Comment

Nigel J Bundred et al. Lancet Oncol. 2020 Nov.

. 2020 Nov;21(11):e499.

doi: 10.1016/S1470-2045(20)30542-8.

¹ Manchester University NHS Foundation Trust, Wythenshawe, Manchester M23 9LT, UK. Electronic address: bundredn@manchester.ac.uk.
² Nuffield Department of Population Health, University of Oxford, Oxford, UK.
³ Leeds Teaching Hospital NHS Trust, Leeds, UK.
⁴ University Hospital Southampton, Southampton, UK.

No abstract available

Comment in

Residual disease after mastectomy.
Wu ZY, Han J, Eom JS, Ahn SH, Ko B. Wu ZY, et al. Lancet Oncol. 2020 Nov;21(11):e500. doi: 10.1016/S1470-2045(20)30526-X. Lancet Oncol. 2020. PMID: 33152292 No abstract available.
Residual disease after mastectomy - Authors' reply.
Kaidar-Person O, Kühn T, Poortmans P. Kaidar-Person O, et al. Lancet Oncol. 2020 Nov;21(11):e501. doi: 10.1016/S1470-2045(20)30622-7. Lancet Oncol. 2020. PMID: 33152293 No abstract available.

Should we worry about residual disease after mastectomy?
Kaidar-Person O, Kühn T, Poortmans P. Kaidar-Person O, et al. Lancet Oncol. 2020 Aug;21(8):1011-1013. doi: 10.1016/S1470-2045(20)30331-4. Lancet Oncol. 2020. PMID: 32758459 No abstract available.